The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2022 | Factors to consider for the optimal management of relapse in multiple myeloma
Yael Cohen, MD, Tel-Aviv Sourasky Medical center, Tel-Aviv, Israel, outlines some of the factors that need to be considered by clinicians when managing patients with multiple myeloma who experience relapse, including type and timing of relapse, treatment toxicity, and presence of comorbidities. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
